TRIB Trinity Biotech
- 1.8300
- 0.00000.00%
Trinity Biotech News
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 424B3: Prospectus
Trinity Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-Perceptive Advisors LLC(26.8%),Perceptive Credit Advisors LLC(26.8%), etc.
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Trinity Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MiCo IVD Holdings, LLC(29.99%),Mainstream Holdings, Ltd.(29.99%), etc.
Trinity Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MiCo Co., Ltd.(0%)
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Trinity Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Trinity Biotech | 20-F: FY2022 Annual Report
Trinity Biotech | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
